• Citer

Recombinant human papillomavirus type 16 E7 protein as a model antigen to study the vaccine potential in control and E7 transgenic mice.

par Gérard, Craig;Baudson, Nathalie ;Kraemer, K;Ledent, Catherine ;Pardoll, D;Bruck, C
Référence Clinical cancer research, 7, 3 Suppl, page (838s-847s)
Publication Publié, 2001-03

Article révisé par les pairs

• Détails
• Contenu

Titre:	Recombinant human papillomavirus type 16 E7 protein as a model antigen to study the vaccine potential in control and E7 transgenic mice.
Auteur:	Gérard, Craig; Baudson, Nathalie; Kraemer, K; Ledent, Catherine; Pardoll, D; Bruck, C
Informations sur la publication:	Clinical cancer research, 7, 3 Suppl, page (838s-847s)
Statut de publication:	Publié, 2001-03
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Animals
	Cancer Vaccines
	Enzyme-Linked Immunosorbent Assay
	Epithelium -- metabolism
	Immunoglobulin G -- metabolism
	Immunohistochemistry
	Mice
	Mice, Inbred C57BL
	Mice, Transgenic
	Oncogene Proteins, Viral -- biosynthesis
	Papillomavirus Vaccines
	Plasmids -- metabolism
	Recombinant Proteins -- metabolism
	T-Lymphocytes, Cytotoxic -- metabolism
	Thyroid Gland -- metabolism
	Time Factors
	Transgenes
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:1078-0432
	info:pmid/11300481